...
首页> 外文期刊>Experimental parasitology >Plasmodium falciparum: sequence analysis of the gene encoding the C-terminus region of the merozoite surface protein-1, a potential malaria vaccine antigen, in Iranian clinical isolates
【24h】

Plasmodium falciparum: sequence analysis of the gene encoding the C-terminus region of the merozoite surface protein-1, a potential malaria vaccine antigen, in Iranian clinical isolates

机译:恶性疟原虫:伊朗临床分离株编码裂殖子表面蛋白-1(潜在的疟疾疫苗抗原)C端区域基因的序列分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1) isolated from different parts of the world revealed sequence variability, however no data exist on sequence heterogeneity of this region from Iran. To address this question, DNA encoding the carboxyl (C)-terminal region of PfMSP-1 was amplified in 144 Iranian P. falciparum clinical isolates, using allele type-specific primers. In this study both MAD20 (88.2%) and K1 (7.6%) types were detected. Sequence analysis of 33 and 92 fragments corresponding to pfmsp-1(42) and pfmsp-1(19) revealed eight (15MAD1-15MAD7 and 15KCH) and five [A1 (E/TSR/L), A2 (Q/KNG/F), A3 (E/KNG/F), A4 (E/TSG/L), and A5 (Q/KNG/L)] distinct haplotypes, respectively. E/TSG/L variant type was the predominant haplotype, and reported only from Thailand and India, but E/KNG/L is widespread in Africa, Asia, and Latin America; but not found among Iranian isolates. In summary, result of this study indicates limited antigenic diversity, and thus support the potential utility of the C-terminal region of PfMSP-1 in designing polyvalent vaccine constructs.
机译:从世界不同地方分离的恶性疟原虫(PfMSP-1)裂殖子表面蛋白-1的C末端区域显示出序列变异性,但是该区域的序列异质性来自伊朗尚无数据。为了解决这个问题,使用等位基因类型特异性引物在144个伊朗恶性疟原虫临床分离株中扩增了编码PfMSP-1羧基(C)末端区域的DNA。在这项研究中,同时检测到MAD20(88.2%)和K1(7.6%)类型。对对应于pfmsp-1(42)和pfmsp-1(19)的33和92个片段的序列分析显示了八个(15MAD1-15MAD7和15KCH)和五个[A1(E / TSR / L),A2(Q / KNG / F) ),A3(E / KNG / F),A4(E / TSG / L)和A5(Q / KNG / L)]不同的单倍型。 E / TSG / L变异型是主要的单倍型,仅在泰国和印度有报道,但E / KNG / L在非洲,亚洲和拉丁美洲很普遍。但在伊朗孤立人群中找不到。总之,这项研究的结果表明有限的抗原多样性,因此支持PfMSP-1 C端区域在设计多价疫苗构建体中的潜在效用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号